Legal Representation
Attorney
Michael Fedrick
USPTO Deadlines
Next Deadline
1928 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-11)
Due Date
February 11, 2031
Grace Period Ends
August 11, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 19, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Aug 29, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Aug 28, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jul 26, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jul 7, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jul 7, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| May 12, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 11, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 11, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 27, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 5, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 13, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 13, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 15, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 27, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jun 27, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jun 14, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| May 29, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 16, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 12, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 9, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Biological preparations for scientific and research use in the fields of chemistry, biology, biotechnology, biopharma, biomedicine, and biochemistry; diagnostic preparations for scientific or research use in the fields of chemistry, biology, biotechnology, biopharma, biomedicine, and biochemistry; chemical reagents for quality control for diagnostics or for scientific purposes, other than for medical or veterinary purposes
Class 005
Active pharmaceutical ingredients for use in drugs in the nature of biological materials and biotechnological materials for the treatment of infectious diseases, inflammation, autoimmune diseases, proliferative disorders and cancer; bacterial preparations for medical and veterinary use; biological preparations for medical purposes for the treatment of infectious diseases, inflammation, autoimmune diseases, proliferative disorders and cancer; enzyme preparations for medical purposes; enzymes for medical purposes; drug delivery agents using liposomes, nanoparticles, fusion proteins, or protein-cage nanoparticles to facilitate the delivery of bacterial and enzyme preparations
Class 040
Custom manufacture and processing of chemicals and ingredients for pharmaceuticals; custom manufacture of bacteriological cultures and reagents; custom manufacture of goods for the pharmaceutical and consumer healthcare industry; custom manufacturing services for drugs
Class 042
Scientific research services in the fields of chemistry, biology, biotechnology, biopharma, biomedicine, and biochemistry; scientific research services regarding high quality intermediates in the fields of chemistry, biology, biotechnology, biopharma, biomedicine, and biochemistry; medical research and pharmaceutical research and development in the fields of chemistry, biology, biotechnology, biopharma, biomedicine, and biochemistry; analytical services in the fields of chemistry, biology, biotechnology, biopharma, biomedicine, and biochemistry, namely, chemical and biochemical analysis, biological and biopharmaceutical testing, and biotechnological assessments in the fields of high-quality intermediates; microbiological analysis
Additional Information
Design Mark
The mark consists of the word "LOBA" in light blue, followed by the word "BIOTECH" in dark blue. In between the wording is a stylized design resembling a helix and four circles in a mixture of light blue and dark blue. The white in the mark is for shading purposes and is not claimed as a feature of the mark.
Color Claim
The color(s) light blue, and dark blue is/are claimed as a feature of the mark.
Classification
International Classes
001
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"